Oncimmune Holdings plc announced that Dr Adam M Hill will be stepping down as Chief Executive Officer, and as a director of the Company. Adam will support Oncimmune in the short term by providing continuity in some of the Company's ongoing commercial efforts and supporting a transition of his responsibilities and relationships to the new CEO and other colleagues as appropriate. Pending the appointment of a permanent successor, the Board has appointed Ron Kirschner, the Company's General Counsel and Company Secretary, as acting CEO, and a director of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.5 GBX | 0.00% | +2.08% | -2.78% |
Feb. 29 | EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout | AN |
Feb. 29 | Oncimmune Holdings plc Provides Earnings Guidance for the Year 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.78% | 23.07M | |
+10.23% | 8.96B | |
-10.76% | 5.19B | |
+51.58% | 4.77B | |
+12.50% | 4.26B | |
-20.70% | 2.37B | |
+12.83% | 2.3B | |
+19.51% | 2.17B | |
-29.65% | 2.21B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ONC Stock
- News Oncimmune Holdings plc
- Oncimmune Holdings plc Announces Executive Changes